BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Srivastava S, Rasool M. Underpinning IL-6 biology and emphasizing selective JAK blockade as the potential alternate therapeutic intervention for rheumatoid arthritis. Life Sciences 2022;298:120516. [DOI: 10.1016/j.lfs.2022.120516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Latif MS, Nawaz A, Asmari M, Uddin J, Ullah H, Ahmad S. Formulation Development and In Vitro/In Vivo Characterization of Methotrexate-Loaded Nanoemulsion Gel Formulations for Enhanced Topical Delivery. Gels 2022;9. [PMID: 36661771 DOI: 10.3390/gels9010003] [Reference Citation Analysis]
2 Garrido-Mesa J, Thomas BL, Dodd J, Spana C, Perretti M, Montero-Melendez T. Pro-resolving and anti-arthritic properties of the MC(1) selective agonist PL8177. Front Immunol 2022;13:1078678. [PMID: 36505403 DOI: 10.3389/fimmu.2022.1078678] [Reference Citation Analysis]
3 Xu Y, Zhang Z, He J, Chen Z. Immune Effects of Macrophages in Rheumatoid Arthritis: A Bibliometric Analysis From 2000 to 2021. Front Immunol 2022;13:903771. [DOI: 10.3389/fimmu.2022.903771] [Reference Citation Analysis]